Titterton Lewis H jr purchased $9K of ANIX
Titterton Lewis H jr purchased 2,797 shares of Anixa Biosciences Inc (ANIX) at $3.28 on 2026-07-15.
How this was made
The 30-second read
Why it matters
The only new information is the director’s open-market purchase details (shares, price, total value, and post-transaction holdings).
Market read
Traders may note a modest insider buy, but there is no accompanying fundamental update to drive repricing.
What to watch
No 10b5-1 plan is stated, but the filing does not disclose intent, timing rationale, or whether other insiders are buying/selling concurrently.
Background
The article is an SEC Form 4 insider transaction disclosure for Anixa Biosciences, reported by a director.
Ticker impact
Anixa Biosciences director Titterton Lewis H jr bought 2,797 shares on 2026-07-15 at $3.2800, totaling $9,174.16.
Near-term price impact is likely limited; any effect would be sentiment-driven rather than fundamental.
Form 4 confirms an insider purchase, but the disclosed dollar value is modest and the filing provides no new operating or financial guidance.
Market effects
No clear sector read-through from a single small insider purchase.
None indicated.
None indicated.
Counterpoint
The purchase could be routine personal liquidity or diversification rather than a strong conviction signal, especially given the small dollar amount.
Key entities
- issuerAnixa Biosciences Inc
Subject of the Form 4 insider transaction; director reported an open-market purchase.
- insiderTitterton Lewis H jr
Director who purchased 2,797 shares at $3.2800 on 2026-07-15.
